OXFORD, ENGLAND & BOSTON, MASS. -- PharmaVentures is pleased to announce that it is to increase its presence in North America by establishing a new base in Boston, MA. Starting this month Dr Adrian Dawkes, VP, will be dividing his time between the USA and the UK. This announcement follows a record year for mandates in M&A and licensing for PharmaVentures.
Technology news on Global TechWire, reporting the business of life
sciences and innovation. Published by Innovative Public Relations, Inc.,
a Research Triangle, North Carolina-based publicity and branding
consultancy. Learn more @ www.innovativepublicrelations.com.
Dr Fintan Walton, CEO, PharmaVentures, commented: "With America still the biggest market for healthcare and with Boston leading life science innovation it makes immense sense for us to have one of our most experienced deal makers on the ground. Increasingly, our clients need access to the opportunities that America offers and Adrian's contacts and experience will be of great value to them."
Dr Adrian Dawkes, VP, added "With a growing number of clients and deals in America, including those involving major pharmaceutical companies such as Pfizer and Merck and other major life science companies, we would like to provide support to leading innovators and healthcare companies in the USA as well as worldwide."
Should you wish to meet up with Adrian to discuss your needs and our capabilities please drop him an email or give him a call on +44 7931 428487, adrian@pharmaventures.com
About PharmaVentures
PharmaVentures is a premier transaction advisory firm and a leader in partnering, M&A deals and strategic alliances. Their unrivalled bank of specialist experience, deal analytics and network of contacts among innovators and large pharma makes them uniquely placed to support businesses in all aspects of deal making and strategic planning. PharmaVentures is well known for its deep insight into deal structures and its success in transactions.
Find out more www.pharmaventures.com
Our services include:
M&A (divestments, mergers, acquisitions and strategic transactions)
Strategy (commercialisation, deal strategy, due diligence, market entry)
Valuation and Positioning (licensing, M&A, fund raising and expert testimonies)
Licensing (in and out licensing)
Expert Testimony (patent infringement, deal disagreements, taxation, determining damages)
Now in its 23rd year, PharmaVentures is based in Oxford, UK, with offices in London, Paris, San Francisco, Auckland and Mexico City.
